Universal Vision Biotechnology Co

Universal Vision Biotechnology Co FCF per Share

The Free Cash Flow per Share of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 13.01 TWD. In the previous year, Free Cash Flow per Share was 14.56 TWD — a change of -10.64% (lower).

FCF per Share

13.01TWD

YoY

-10.64%

Last updated:

Free Cash Flow per Share of Universal Vision Biotechnology Co is 2025 13.01 TWD. Free Cash Flow per Share of Universal Vision Biotechnology Co was 2024 14.56 TWD. It decreases by -10.64% lower compared to the previous year.

The Universal Vision Biotechnology Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
0.90 TWD
Jan 1, 2019
2.42 TWD
Jan 1, 2020
6.94 TWD
Jan 1, 2021
7.66 TWD
Jan 1, 2022
9.13 TWD
Jan 1, 2023
12.69 TWD
Jan 1, 2024
14.56 TWD
Jan 1, 2025
13.01 TWD
The Universal Vision Biotechnology Co FCF per Share history
YEARFCF per ShareYoY
13.01TWD-10.64%
14.56TWD+14.74%
12.69TWD+39.01%
9.13TWD+19.20%
7.66TWD+10.31%
6.94TWD+187.28%
2.42TWD+169.49%
0.90TWD-32.91%
1.34TWD-26.54%
1.82TWD-182.88%
-2.20TWD-443.23%
0.64TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

Free Cash Flow per Share of Universal Vision Biotechnology Co is 13.01 TWD in 2025.

Free Cash Flow per Share of Universal Vision Biotechnology Co changed from 14.56 TWD to 13.01 TWD, representing a -10.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Universal Vision Biotechnology Co

All Key Metrics — Universal Vision Biotechnology Co